Kato Y, Haraguchi K, Kawashima M, Yamada S, Isogai M, Masuda Y, Kimura R
School of Pharmaceutical Sciences, University of Shizuoka, Japan.
Chem Biol Interact. 1995 Apr 14;95(3):269-78. doi: 10.1016/0009-2797(94)03565-p.
The inducing potency of 3-methylsulphonyl(MeSO2)-2,2',4',5,5'-pentachlorobiphenyl (pentaCB), which was one of the major MeSO2 metabolites of polychlorinated biphenyls (PCBs) present in seal blubber, on the hepatic drug metabolizing enzyme activities was examined in comparison with that of the parent compound and phenobarbital (PB). The inducing fashion of the above enzymes and changes in the contents of PB-inducible P-450 forms by 2,3',4',5-tetrachlorobiphenyl (tetraCB) (IU-70), 2,2',3',4',5-pentaCB (IU-87), 2,2',4',5,5'-pentaCB (IU-101) and 2,2',3',4',5,5'-hexachlorobiphenyl (hexaCB) (IU-141), and their MeSO2 metabolites were investigated in rats. Administration at various doses (0.2-1.0 mumol/kg) of 3-MeSO2-2,2',4',5,5'-pentaCB produced nearly dose-related increases in the hepatic concentration of this methyl sulphone, in the contents of cytochromes P-450 and b5, and in activities of aminopyrine N-demethylase, 7-ethoxycoumarin O-deethylase and benzo[a]pyrene hydroxylase of liver microsomes. Major PB-inducible forms, CYP2B1, CYP2B2, CYP3A2 and CYP2C6 were induced with four PCBs (342 mumol/kg) and their 3-MeSO2 metabolites (0.5-10 mumol/kg), indicating that 3-MeSO2 metabolites were strong PB-type inducers of hepatic drug-metabolizing enzymes. 3-MeSO2-2,2',4',5,5'-pentaCB was an especially strong inducer. On the other hand, four PB-inducible forms of cytochrome P-450 were not induced with the 4-MeSO2 isomers. The relation between liver concentrations of the corresponding 3-MeSO2 derivatives and induction of four PB-inducible forms of cytochrome P-450 after administration of four PCBs and their 3-MeSO2 derivatives further confirmed that the 3-MeSO2 metabolites played an important role in the induction which parent PCB congeners caused on the hepatic drug-metabolizing enzyme system.
海豹脂肪中存在的多氯联苯(PCBs)的主要甲磺酰基(MeSO2)代谢产物之一3-甲基磺酰基(MeSO2)-2,2',4',5,5'-五氯联苯(五氯联苯)对肝脏药物代谢酶活性的诱导能力,与母体化合物和苯巴比妥(PB)进行了比较研究。研究了2,3',4',5-四氯联苯(四氯联苯)(IU-70)、2,2',3',4',5-五氯联苯(IU-87)、2,2',4',5,5'-五氯联苯(IU-101)和2,2',3',4',5,5'-六氯联苯(六氯联苯)(IU-141)及其MeSO2代谢产物对上述酶的诱导方式以及PB诱导的P-450形式含量的变化。给大鼠以不同剂量(0.2 - 1.0 μmol/kg)的3-MeSO2-2,2',4',5,5'-五氯联苯给药后,该甲砜在肝脏中的浓度、细胞色素P-450和b5的含量以及肝微粒体中氨基比林N-脱甲基酶、7-乙氧基香豆素O-脱乙基酶和苯并[a]芘羟化酶的活性均呈现出几乎与剂量相关的增加。四种多氯联苯(342 μmol/kg)及其3-MeSO2代谢产物(0.5 - 10 μmol/kg)诱导了主要的PB诱导形式CYP2B1、CYP2B2、CYP3A2和CYP2C6,表明3-MeSO2代谢产物是肝脏药物代谢酶的强PB型诱导剂。3-MeSO2-2,2',4',5,5'-五氯联苯是一种特别强的诱导剂。另一方面,4-MeSO2异构体未诱导出细胞色素P-450的四种PB诱导形式。四种多氯联苯及其3-MeSO2衍生物给药后,相应3-MeSO2衍生物的肝脏浓度与细胞色素P-450的四种PB诱导形式的诱导之间的关系进一步证实,3-MeSO2代谢产物在母体多氯联苯同系物对肝脏药物代谢酶系统的诱导中起重要作用。